To better understand the stage(s) of differentiation reached by B-type chronic lymphocytic leukemia (B-CLL) cells and to gain insight into the potential role of antigenic stimulation in the development and diversification of these cells, we analyzed the rearranged VH genes expressed by 83 B-CLL cells (64 IgM+ and 19 non-IgM+). Our results confirm and extend the observations of a bias in the use of certain VH, D, and JH genes among B-CLL cells. In addition, they indicate that the VH genes of approximately 50% of the IgM+ B-CLL cells and approximately 75% of the non-IgM+ B-CLL cells can exhibit somatic mutations. The presence of mutation varies according to the VH family expressed by the B-CLL cell (VH3 expressers displaying more mutation than VH1 and VH4 expressers). In addition, the extent of mutation can be sizeable with approximately 32% of the IgM+ cases and approximately 68% of the non-IgM+ cases differing by > 5% from the most similar germline gene. Approximately 20% of the mutated VH genes display replacement mutations in a pattern consistent with antigen selection. However, CDR3 characteristics (D and JH gene use and association and HCDR3 length, composition, and charge) suggest that selection for distinct B cell receptors (BCR) occurs in many more B-CLL cells. Based on these data, we suggest three prototypic BCR, representing the VH genes most frequently encountered in our study. These data suggest that many B-CLL cells have been previously stimulated, placing them in the "experienced" or "memory" CD5(+) B cell subset.
F Fais, F Ghiotto, S Hashimoto, B Sellars, A Valetto, S L Allen, P Schulman, V P Vinciguerra, K Rai, L Z Rassenti, T J Kipps, G Dighiero, H W Schroeder Jr, M Ferrarini, N Chiorazzi
Title and authors | Publication | Year |
---|---|---|
Total proteome analysis identifies migration defects as a major pathogenetic factor in IGHV-unmutated chronic lymphocytic leukemia
GL Eagle, J Zhuang, RE Jenkins, KJ Till, PV Jithesh, K Lin, GG Johnson, M Oates, K Park, NR Kitteringham, AR Pettitt |
Molecular & cellular proteomics : MCP | 2015 |
Immunoglobulin transcript sequence and somatic hypermutation computation from unselected RNA-seq reads in chronic lymphocytic leukemia
JS Blachly, AS Ruppert, W Zhao, S Long, J Flynn, I Flinn, J Jones, K Maddocks, L Andritsos, EM Ghia, LZ Rassenti, TJ Kipps, A la Chapelle, JC Byrd |
Proceedings of the National Academy of Sciences | 2015 |
Excessive antigen reactivity may underlie the clinical aggressiveness of chronic lymphocytic leukemia stereotyped subset #8
M Gounari, S Ntoufa, B Apollonio, N Papakonstantinou, M Ponzoni, CC Chu, D Rossi, G Gaidano, N Chiorazzi, K Stamatopoulos, P Ghia |
Blood | 2015 |
Restricted, canonical, stereotyped and convergent immunoglobulin responses
CJ Dunand, PC Wilson |
Philosophical Transactions of the Royal Society B: Biological Sciences | 2015 |
Survival of human lymphoma cells requires B-cell receptor engagement by self-antigens
RM Young, T Wu, R Schmitz, M Dawood, W Xiao, JD Phelan, W Xu, L Menard, E Meffre, WC Chan, ES Jaffe, RD Gascoyne, E Campo, A Rosenwald, G Ott, J Delabie, LM Rimsza, LM Staudt |
Proceedings of the National Academy of Sciences | 2015 |
VDJSeq-Solver: In Silico V(D)J Recombination Detection Tool
G Paciello, A Acquaviva, C Pighi, A Ferrarini, E Macii, A Zamo’, E Ficarra, Q Shi |
PloS one | 2015 |
The complex interplay between cell-intrinsic and cell-extrinsic factors driving the evolution of chronic lymphocytic leukemia
LA Sutton, R Rosenquist |
Seminars in Cancer Biology | 2015 |
Cytoplasmic myosin-exposed apoptotic cells appear with caspase-3 activation and enhance CLL cell viability
X Cui, L Zhang, AR Magli, R Catera, XJ Yan, DO Griffin, TL Rothstein, J Barrientos, JE Kolitz, SL Allen, KR Rai, N Chiorazzi, CC Chu |
Leukemia | 2015 |
“IDENTIFYING HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA: A PATHOGENESIS-ORIENTED APPRAISAL OF PROGNOSTIC AND PREDICTIVE FACTORS IN PATIENTS TREATED WITH CHEMOTHERAPY WITH OR WITHOUT IMMUNOTHERAPY.”
S Martinelli, A Cuneo, GM Rigolin |
Mediterranean journal of hematology and infectious diseases | 2015 |
Generation of a poor prognostic chronic lymphocytic leukemia-like disease model: PKC subversion induces up-regulation of PKC II expression in B lymphocytes
R Nakagawa, M Vukovic, A Tarafdar, E Cosimo, K Dunn, AM McCaig, A Holroyd, F McClanahan, AG Ramsay, JG Gribben, AM Michie |
Haematologica | 2015 |
Del(20q) in patients with chronic lymphocytic leukemia: a therapy-related abnormality involving lymphoid or myeloid cells
CC Yin, G Tang, G Lu, X Feng, MJ Keating, LJ Medeiros, LV Abruzzo |
Modern Pathology | 2015 |
Current Topics in Microbiology and Immunology
K Okkenhaug, JA Burger |
Current topics in microbiology and immunology | 2015 |
Paradigm shifts in the management of poor-risk chronic lymphocytic leukemia
RD Innis-Shelton, RS Davis, L Lamb, S Mineishi |
Leukemia & Lymphoma | 2015 |
Hypermorphic mutation of phospholipase C, 2 acquired in ibrutinib-resistant CLL confers BTK independency upon B-cell receptor activation
TM Liu, JA Woyach, Y Zhong, A Lozanski, G Lozanski, S Dong, E Strattan, A Lehman, X Zhang, JA Jones, J Flynn, LA Andritsos, K Maddocks, SM Jaglowski, KA Blum, JC Byrd, JA Dubovsky, AJ Johnson |
Blood | 2015 |
Regulatory network reconstruction reveals genes with prognostic value for chronic lymphocytic leukemia
S Yepes, MM Torres, L López-Kleine |
BMC Genomics | 2015 |
Do Biologic Parameters Affect the Time to First Treatment of Clinical Monoclonal B-Cell Lymphocytosis and Chronic Lymphocytic Leukemia Rai Stage 0? Results of a Prospective Analysis
S Molica, D Giannarelli, L Levato, M Gentile, R Mirabelli, F Morabito |
Clinical Lymphoma Myeloma and Leukemia | 2015 |
High-Throughput Sequencing Using the Ion Torrent Personal Genome Machine for Clinical Evaluation of Somatic Hypermutation Status in Chronic Lymphocytic Leukemia
R McClure, M Mai, S McClure |
The Journal of Molecular Diagnostics | 2015 |
ASSOCIATION BETWEEN GENE AND MIRNA EXPRESSION PROFILES AND STEREOTYPED SUBSET #4 B-CELL RECEPTOR IN CHRONIC LYMPHOCYTIC LEUKEMIA
F Maura, G Cutrona, L Mosca, S Matis, M Lionetti, S Fabris, L Agnelli, M Colombo, C Massucco, M Ferracin, B Zagatti, D Reverberi, M Gentile, AG Recchia, S Bossio, D Rossi, G Gaidano, S Molica, A Cortelezzi, FD Raimondo, M Negrini, P Tassone, F Morabito, M Ferrarini, A Neri |
Leukemia & Lymphoma | 2015 |
Unavailability of thymidine kinase does not preclude the use of German comprehensive prognostic index: results of an external validation analysis in early chronic lymphocytic leukemia and comparison with MD Anderson Cancer Center model
S Molica, D Giannarelli, R Mirabelli, L Levato, A Russo, M Linardi, M Gentile, F Morabito |
European Journal of Haematology | 2015 |
Chronic lymphocytic leukemia/small lymphocytic lymphoma: another neoplasm related to the B-cell follicle?
B Tandon, SH Swerdlow, RP Hasserjian, U Surti, SE Gibson |
Leukemia & Lymphoma | 2015 |
A new piece to the stereotypy ‘puzzle’ in chronic lymphocytic leukemia
R Rosenquist |
Leukemia & Lymphoma | 2015 |
Developing Molecular Signatures for Chronic Lymphocytic Leukemia
E Cornet, A Debliquis, V Rimelen, N Civic, M Docquier, X Troussard, B Drénou, T Matthes, M Baudis |
PloS one | 2015 |
Immunoglobulin gene expression in umbilical cord blood-derived CD34+ hematopoietic stem/progenitor cells
J Liu, M Xia, P Wang, C Wang, Z Geng, CC Yin, C Zhang, X Qiu |
Gene | 2015 |
Application of biomarkers in oncology clinical trials
N Dakappagari, H Gong, R Pollner, A Siva, S Tangri, J Lameh |
Clinical Investigation | 2015 |
SF3B1 and IGHV gene mutation status predict poor prognosis in Japanese CLL patients
T Mitsui, H Koiso, H Nakahashi, A Saitoh, H Shimizu, T Ishizaki, Y Ogawa, M Takizawa, A Yokohama, T Saitoh, T Jinbo, H Ogura, H Handa, M Sawamura, T Sakura, M Karasawa, H Murakami, Y Nojima, N Tsukamoto |
International Journal of Hematology | 2015 |
The role of B-cell receptor inhibitors in the treatment of patients with chronic lymphocytic leukemia
A Wiestner |
Haematologica | 2015 |
IGK with conserved IGΚV/IGΚJ repertoire is expressed in acute myeloid leukemia and promotes leukemic cell migration.
Wang C, Xia M, Sun X, He Z, Hu F, Chen L, Bueso-Ramos CE, Qiu X, Yin CC |
Oncotarget | 2015 |